TRI – Thrombosis Research Institute – Innovators in Thrombosis

Patron

HRH The Prince Philip
Duke of Edinburgh KG KT

Court of Patrons

The Most Hon The Marquess
of Salisbury KCVO PC DL (Chairman)
Sir Michael Edwardes
Mr David McDonough OBE
Mr Björn Saven
Sir Julian Seymour CBE
The Lord Sherbourne of Didsbury CBE
Sir Mark Worthington OBE

Founder

Professor V.V. Kakkar
OBE FRCS FRCSE Hon DSc

Trustees

Mr Patrick Burgess MBE OBE DL (Chairman)
Dr Jeffrey Herbert
Mr Guy Weston
The Rt. Hon. Lord Neuberger of Abbotsbury
Sir Ralph Waller

Director

Rt. Hon. Professor The Lord Kakkar PC

Deputy Director/Chief Operating Officer

Ms Gloria Kayani

Latest Tweets

Thrombosis Research Institute @TRI_Thrombosis·

15 Feb 1361275270905401346

Just published our quarterly newsletter, TRI in Focus. This issue looks at what's driving demand for data in healthcare, how CROs are evolving their ops amid the pandemic and more. Get it here: https://t.co/KpieN0HVF9

Reply on Twitter 1361275270905401346 Retweet on Twitter 1361275270905401346 Like on Twitter 1361275270905401346 Twitter 1361275270905401346

Retweet on Twitter Thrombosis Research Institute Retweeted

Michael Makris @ProfMakris·

11 Feb 1359955496946589697

The UK authorities have approved Rivaroxaban for use in children from birth to 18 years. This will make anticoagulation in this patient group so much easier.

Reply on Twitter 1359955496946589697 Retweet on Twitter 135995549694658969746 Like on Twitter 1359955496946589697132 Twitter 1359955496946589697

Thrombosis Research Institute @TRI_Thrombosis·

9 Feb 1359132973841399813

Excellent awareness work from @ThromboAdviser

Thrombosis Adviser@ThromboAdviser

Do you #KnowThrombosis? #VTE is often preventable; however, 25% of patients are still at risk of VTE-related mortality. Share this infographic from @thrombosisday to raise awareness of the risk factors, signs and symptoms of #thrombosis.

Reply on Twitter 1359132973841399813 Retweet on Twitter 1359132973841399813 Like on Twitter 1359132973841399813 Twitter 1359132973841399813

Retweet on Twitter Thrombosis Research Institute Retweeted

JTH @JTHjournal·

8 Feb 1358905780741656576

New #COVIDー19 📰 📈venous #thrombosis #VTE risk in (non)severe hospitalized #COVIDー19 pts. Li et al show risk factors are aging, #cancer & lower
fibrinogen. D-dimer 📈≥1.5x most significant factor➡️ VTE in hospitalized COVID-19 patients.
https://t.co/riSzlWjoKE #openaccess

Reply on Twitter 1358905780741656576 Retweet on Twitter 135890578074165657630 Like on Twitter 135890578074165657642 Twitter 1358905780741656576

Retweet on Twitter Thrombosis Research Institute Retweeted

Michael Makris @ProfMakris·

4 Feb 1357471996150448130

James O'Donnell explained that the pulmonary thrombosis in patients with #COVID19 is usually different from the classic pulmonary emboli where the thrombus originated in the legs. #EAHAD2021 #thrombosis

Reply on Twitter 1357471996150448130 Retweet on Twitter 135747199615044813016 Like on Twitter 135747199615044813043 Twitter 1357471996150448130

QUICK LINKS

Thrombosis News

More news >

TRI announce new clinical trial ETHIC

Click to view the article
Article source: TRI

Our work continues: May COVID-19 update from...

GARFIELD-AF Risk Calculator launched on Calculate by...

World Thrombosis Day – 5 Years On

Click to view the article
Article source: The Lancet

Scientists identify biomarkers to predict risk of...

Click to view the article
Article source: News Medical

Alcohol abstinence reduces arrhythmia recurrences, BP in...

Click to view the article
Article source: Healio (Cardiology Today)

Interfacility transfer may increase risk of venous...

Click to view the article
Article source: Healio

Introduction to TRI

View brochure

Click here to scroll down to the page content

TRI: Past, Present and Future

Hear more about how TRI started and what it does today.

Our Mission

At the Thrombosis Research Institute, we are committed to saving millions of lives, preventing long term disability and reducing healthcare costs by delivering pioneering advances in the detection, prevention and treatment of thrombosis.

Get the details

Our Achievements

Our multi-disciplinary programme of laboratory and clinical research has contributed to major advances in venous thromboembolism that have changed clinical practice, and enhanced knowledge and management of atrial fibrillation.

Get the details

Our Research

The Thrombosis Research Institute has been at the centre of global understanding of thrombosis for several decades, producing the highest calibre research into the condition.

Get the details